Addus HomeCare (ADUS)
Provides in-home personal care, hospice, and home health services.
Something off on this page? Send us feedback.
Provides in-home personal care, hospice, and home health services, earning revenue from government programs, managed care organizations, insurers, and private-pay clients. Personal care generates most revenue, while acquisitions expand local density and clinical reach; the model depends on caregiver availability and regulated reimbursement.
Provides in-home personal care, hospice, and home health services across U.S. state markets. Personal care, the anchor segment, helps older adults and people with chronic illnesses or disabilities with activities of daily living. Hospice delivers physical, emotional, and spiritual support for terminally ill patients and their families, while home health supplies skilled nursing and rehabilitation after illness or hospitalization.
Combines organic expansion with acquisitions that deepen local density, add state markets, and extend clinical services; selected states offer all three levels of care. Revenue comes from federal, state, and local programs, managed care organizations, commercial insurers, and private-pay clients, and many consumers qualify for both Medicare and Medicaid.
Operations depend on caregiver recruitment and retention, reimbursement rates, licensing and program rules, and integration of acquired agencies.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 14, 2026 | Citigroup | Downgrade | ||
| Sep 14, 2026 | Raymond James | Target | Target: — | Target: $125 |
| Sep 14, 2026 | Bank of America Securities | Downgrade | ||
| Sep 14, 2026 | B of A Securities | Downgrade | ||
| Aug 5, 2026 | RBC Capital | Reiterate | Rating: —Target: $139 | Target: $134 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $99.6M · Total debt $108.8M · Total assets $1.46B · Shareholders' equity $1.15B
- Revenue
- $377.4M
- Operating income
- $38.9M
- Net income
- $27.6M
No dividends on record.
| Institutions | 105.35% | 19.67M shares | |
|---|---|---|---|
| 306 holders · as of Jun 30, 2026 | |||
| Insiders | 2.85% | 532.9K shares | |
| 18 holders · as of Aug 17, 2026 | |||
| Adds to | 108.20% | ||
18.67M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 108.20%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 18.34% | 3.43M | as of Jun 30, 2026 |
Capital Research Global InvestorsInstitution | 7.44% | 1.39M | as of Jun 30, 2026 |
Dimensional Fund Advisors LPInstitution | 4.47% | 835,163 | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 4.23% | 789,325 | as of Jun 30, 2026 |
State Street CorpInstitution | 4.17% | 777,826 | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 22, 2026 | Heather Brianne Dixon | officer: President and Chief Operating | −288 | $93.77 |
| May 21, 2026 | Esteban Lopez | director | −250 | $93.00 |
| May 19, 2026 | Esteban Lopez | director | −250 | $93.00 |
| Apr 21, 2026 | Cliff Donald Blessing | officer: EVP, Chief Development Officer | −178 | $93.61 |
| Mar 2, 2026 | Monica Raines | officer: EVP, CCO and Quality Officer | −224 | $102.15 |
- BrightSpring Health Services
Broad HCBS platform with personal care and clinical overlap
- Aveanna Healthcare
Medicaid-heavy private-duty and home-health peer
- The Pennant Group
Regional home health and hospice operator with home care exposure
- UnitedHealth Group
Optum adds large-scale home health and hospice pressure
- Chemed
VITAS makes hospice the direct overlap
- Humana
CenterWell creates payer-owned home-health overlap
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Addus HomeCare | $114.76 | +0.46% | $2.13B | 20.0 | 15.9 | 1.4 | +8.0% |
| BrightSpring Health Services | $55.92 | −1.12% | $11.10B | 42.2 | 27.4 | 0.8 | +23.0% |
| Aveanna Healthcare | $12.85 | −2.80% | $2.88B | 10.5 | 15.0 | 1.1 | +13.7% |
| The Pennant Group | $39.33 | −0.22% | $1.37B | 43.8 | 27.1 | 1.2 | +35.8% |
| UnitedHealth Group | $371.23 | −0.46% | $338.69B | 24.0 | 17.4 | 0.8 | +0.4% |
| Chemed | $500.57 | +0.80% | $6.49B | 24.9 | 19.5 | 2.5 | +8.8% |
| Humana | $376.64 | +1.27% | $44.66B | 35.2 | 30.6 | 0.3 | +26.2% |
| Median | 30.1 | 23.3 | 0.9 | +18.4% |